Skip to Main Content

Author Details

Linghua Wang
The University of Texas M. D. Anderson
2006
100
34
PMIDPaper TitleJournal TitlePublished Year
37717856Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.J Thorac Oncol2024
34789422Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer.Eur Urol Oncol2023
37479893Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance.Commun Biol2023
37586321Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells.Cell Rep Med2023
37547313Effect of neonatal and adult sepsis on inflammation-related diseases in multiple physiological systems: a Mendelian randomization study.Front Endocrinol (Lausanne)2023
37738407Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases.Cancer Res2023
37604642T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy.J Immunother Cancer2023
37419119Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression.Cancer Cell2023
37248301Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.Nat Med2023
37311413Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease.Cancer Cell2023
37467716TimiGP: Inferring cell-cell interactions and prognostic associations in the tumor immune microenvironment through gene pairs.Cell Rep Med2023
37264184Early stage gastric adenocarcinoma: clinical and molecular landscapes.Nat Rev Clin Oncol2023
37164011Deciphering tumor ecosystems at super resolution from spatial transcriptomics with TESLA.Cell Syst2023
37066184Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.bioRxiv2023
37327788MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma.Cancer Cell2023
36865791A new intronic quantitative PCR method led to the discovery of transformation from human ascites to murine malignancy in a mouse model.Front Oncol2023
36627494Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.Nature2023
36002248Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.Gut2023
34797699Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma.J Clin Oncol2022
35512184Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.Blood2022
35705814Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.Nature2022
35379845MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.Nat Commun2022
35687817Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.Blood Cancer Discov2022
35748201Distinguishing T1-2 and T3a tumors of rectal cancer with texture analysis and functional MRI parameters.Diagn Interv Radiol2022
35413951Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.Nat Commun2022
36099884Spatial transcriptomics.Cancer Cell2022
36098652The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.Cancer Discov2022
35992107A systematic review and meta-analysis of endocrine-related adverse events associated with interferon.Front Endocrinol (Lausanne)2022
36163179TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma.Mol Cancer2022
36321308Developmental Deconvolution Suggests New Tumor Biology and a Tool for Predicting Cancer Origin.Cancer Discov2022
33785559Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting <i>ARID1A</i> deficiency.Gut2022
35074072Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (⿤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.Lancet Oncol2022
35181787Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.Cancer Immunol Res2022
35020640Lesion-Based Radiomics Signature in Pretherapy 18F-FDG PET Predicts Treatment Response to Ibrutinib in Lymphoma.Clin Nucl Med2022
32345613YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition.Gut2021
33491779Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib.Am J Hematol2021
33766033Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma.Mol Cancer2021
33514726Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas.Nat Commun2021
33809063Single-Cell Expression Landscape of SARS-CoV-2 Receptor <i>ACE2</i> and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients.Cancers (Basel)2021
33552049Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications.Front Immunol2021
34941392Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.Science2021
34529467Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.Science2021
345566689p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy.Nat Commun2021
34663807Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.Nat Commun2021
34723252Computational immune infiltration analysis of pediatric high-grade gliomas (pHGGs) reveals differences in immunosuppression and prognosis by tumor location.Comput Syst Oncol2021
34422660Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With Outcomes.Front Oncol2021
34771465Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes.Cancers (Basel)2021
34041526CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel.Blood2021
34001881Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.Nat Commun2021
33972311Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing.Cancer Discov2021
  • 1 - 50 of 100

Recommended Authors

Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 2
Reyka G Jayasinghe
Washington University in St Louis
Career Start Year 2015
Number of shared co-authors 18
Jihye Park
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2015
Number of shared co-authors 2
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 4
Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 2
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 1
Michael Bockmayr
Institute of Pathology, Charite Universitatsmedizin Berlin
Career Start Year 2013
Number of shared co-authors 0
Hiroko Tanaka
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 4
Jiguang Wang
The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 9
Francesco Favero
Universita del Piemonte Orientale
Career Start Year 2010
Number of shared co-authors 2
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 34
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 30
Xinmin Li
University of California los angeles
Career Start Year 2008
Number of shared co-authors 1
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 48
Samuel S Freeman
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 10
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 8
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 5
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 43
Fengshen Kuo
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 10
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 2
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 11
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 23
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 11
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 15
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 26
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 18
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 2
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 16
Timothy A Chan
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 36

Collaborators

Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers 22
David A Wheeler
Baylor College of Medicine
Co-authored papers 17
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Co-authored papers 13
Jennifer A Wargo
Co-authored papers 12
Xingzhi Song
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
Hussein A Tawbi
MD Anderson Cancer Center
Co-authored papers 9
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Francisco Vega
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Donna M Muzny
Baylor College of Medicine
Co-authored papers 7
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers 7
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Harshavardhan Doddapaneni
Baylor College of Medicine
Co-authored papers 6
Shu Zhang
The Second Affiliated Hospital of Xi'an Jiaotong University
Co-authored papers 5
Richard A Gibbs
Baylor College of Medicine
Co-authored papers 5
Mingyao Li
Co-authored papers 4
Hui Shen
Van Andel Institute
Co-authored papers 4
Peter W Laird
Van Andel Institute
Co-authored papers 4
Timothy P Heffernan
Co-authored papers 4
Ken Chen
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Paul Scheet
University of Texas M.D. Anderson Cancer Center
Co-authored papers 3
Kristen Leraas
Nationwide Children's Hospital
Co-authored papers 3
Jean Claude Zenklusen
National Cancer Institute
Co-authored papers 3
Janice N Cormier
Co-authored papers 3
Guillermo Garcia-Manero
MD Anderson Cancer Center
Co-authored papers 3
Steven M Dubinett
David Geffen School of Medicine at university of california los angeles
Co-authored papers 3
Avrum Spira
Boston University School of Medicine
Co-authored papers 3
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Release 1.2